CFO at Byrna Technologies (BYRN) awarded time- and performance-based RSUs
Rhea-AI Filing Summary
KEARNES LAURILEE reported acquisition or exercise transactions in this Form 4 filing.
Byrna Technologies Inc. reported that Chief Financial Officer Laurilee Kearnes received two grants of restricted stock units on March 17, 2026, each covering 18,210 RSUs. Each RSU represents a contingent right to receive one share of Byrna common stock.
One RSU grant was issued under the company’s Long Term Incentive Program and vests in three equal tranches on March 17, 2027, March 2, 2028 and March 2, 2029, subject to continued service, with accelerated vesting upon death, disability or certain qualifying terminations following a change of control. The second grant is performance-based and can vest on November 30, 2028 if preset revenue levels for the fiscal year ending November 30, 2027 are achieved and specified employment conditions are met, with similar acceleration protections.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 18,210 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 18,210 | $0.00 | -- |
Footnotes (1)
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Byrna Technologies Inc. (the "Issuer"). The RSUs were granted pursuant to the Issuer's Long Term Incentive Program. They vest in three equal tranches on March 17, 2027, March 2, 2028 and March 2, 2029, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Such vesting will be accelerated upon the death or disability of the Reporting Person or upon the termination of the Reporting Person without cause or resignation by the Reporting Person for good reason within 12 months following a qualifying change of control transaction. The RSUs were granted pursuant to the Issuer's Long Term Incentive Program. They are performance-based and will vest on November 30, 2028 if and to the extent that (a) the Issuer achieves preset revenue levels for its fiscal year ending November 30, 2027 and (b) the Reporting Person (i) remains employed by the Issuer through November 30, 2028 or (ii) is terminated without cause after November 30, 2027. Such vesting will be accelerated upon the death or disability of the Reporting Person or upon the termination of the Reporting Person without cause or resignation by the Reporting Person for good reason within 12 months following a qualifying change of control transaction.